Skip to main content

Helping you get your patients get back to routine care

The reliable testing and accurate insights you need

Many patients have deferred routine testing and medical care since the start of the COVID-19 pandemic:

Our Patient Service Centers put patient care first every day

Our Patient Services Centers are open and ready to help your patients get the testing for routine, acute, and chronic conditions they may have delayed due to COVID-19. All locations have implemented enhanced safety precautions and our Peace of Mind program.

Download the Peace of Mind brochure

Supporting your efforts in getting back to patient care

While we know all practices will have variations on how to get back to patient care, we’ve developed a baseline approach, based on CDC guidelines, to help guide and provide insights.

  • Evaluate COVID-19 status to support patient office visits
  • Manage risk as you and your patients return to traditional care pathways—routine, acute, and chronic care
  • Continue to optimize telehealth models
  • Utilize our Patient Service Centers for routine testing

*Specimen collection for molecular testing for active COVID-19 infection is not available in our Patient Service Centers.

**CPT codes are based on American Medical Association guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.

Download our program brochure for an example
model of how to get back to patient care

Download our Peace of Mind brochure to learn
how we make it easier to access the routine
testing you need from Quest

Learn more about Quest Diagnostics’
comprehensive response to COVID-19 including
resources to support telehealth

We are committed to providing accurate insights about COVID-19 status to help you make actionable suggestions for your patients considering resuming daily routines.

References

  1. Cohen O, Fox B, Mills N, Wright P. COVID-19 and commercial pharma: navigating an uneven recovery. McKinsey & Company. April 2020. Accessed May 1, 2020. https://www.mckinsey.com/industries/pharmaceuticals-and-medical-products/our-insights/covid-19-and-commercial-pharma-navigating-an-uneven-recovery
  2. Mehrotra A, Chernew M, Linetsky D, Hatch H., The impact of the COVID-19 pandemic on outpatient visits: a rebound emerges. To the Point (blog), The Commonwealth Fund. Updated May 19, 2020. doi: doi.org/10.26099/ds9e-jm36

During the COVID-19 health crisis, fast action and trusted information matter more than ever.

Find out what's happening

Learn More